Dopaminergic and cholinergic lesions in progressive supranuclear palsy. - Wikidata - awgldk - TriplyDB

Dopaminergic and cholinergic lesions in progressive supranuclear palsy.

Dopaminergic and cholinergic lesions in progressive supranuclear palsy.

http://www.wikidata.org/entity/Q42205368

about

Alzheimer's disease: Targeting the Cholinergic System Progressive supranuclear palsy.Donepezil in the treatment of progressive supranuclear palsy.Cerebrospinal fluid acetylcholinesterase in progressive supranuclear palsy: reduced activity relative to normal subjects and lack of inhibition by oral physostigmine Acetylcholinesterase and butyrylcholinesterase activity in the cerebrospinal fluid of patients with neurodegenerative diseases involving cholinergic systems Striatal phosphoproteins in Parkinson disease and progressive supranuclear palsy.Differential diagnosis of Parkinson's disease, multiple system atrophy, and Steele-Richardson-Olszewski syndrome: discriminant analysis of striatal 18F-dopa PET data Neuronal loss in the pedunculopontine tegmental nucleus in Parkinson disease and in progressive supranuclear palsy Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism.Cholinergic modulation of the cortical neuronal network.The basal ganglia cholinergic neurochemistry of progressive supranuclear palsy and other neurodegenerative diseases.Olfaction in Parkinson's disease and related disorders.Brain muscarinic receptors in progressive supranuclear palsy and Parkinson's disease: a positron emission tomographic study.Biologic effects of nerve growth factor on lesioned basal forebrain neurons.Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson's disease.Mitochondrial toxins in Basal Ganglia disorders: from animal models to therapeutic strategies.Clinical trials: past, current, and future for atypical Parkinsonian syndromes.Toxicity of Annonaceae for dopaminergic neurons: potential role in atypical parkinsonism in Guadeloupe.Progressive supranuclear palsy: progression and survival.Abnormalities in corticotropin-releasing hormone (CRH) in Alzheimer's disease and other human disorders.Progressive supranuclear palsy: a brief personalized history.Brain somatostatin concentrations do not decrease in progressive supranuclear palsy.Cholinergic imaging in corticobasal syndrome, progressive supranuclear palsy and frontotemporal dementia.Neurodegeneration in the limbic and paralimbic system in progressive supranuclear palsy.Impulsive-compulsive spectrum behaviors in pathologically confirmed progressive supranuclear palsy.Combination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA, and PSP.Levodopa-induced dyskinesia in an autopsy-proven case of progressive supranuclear palsy.Neurotransmitter deficits from frontotemporal lobar degeneration.[123I]beta-CIT SPECT in multiple system atrophy, progressive supranuclear palsy, and corticobasal degeneration.Transcranial AC pulsed applications of weak electromagnetic fields reduces freezing and falling in progressive supranuclear palsy: a case report.Neuropsychiatric disturbances in atypical parkinsonian disorders

P2860

Q28070135-69A1601C-B394-4DC6-BEDC-9F7E2F3A7AB5 Q30493367-6E11713D-C06D-42FD-A3CD-A07F117403E0 Q32066353-B7F25DFC-D746-4DA5-AB67-4832F59F86D4 Q33589820-4E4DC56D-7D43-4378-A6F4-8795BAEACB53 Q33628334-0B803E61-69AB-408A-A9D1-E526D2978E4A Q33848823-A9044F3D-8AF3-4287-B37C-EFD71BC76D49 Q34060625-F7070F30-D4EA-4C35-A3A9-AD4F8B2BD45E Q34340994-1D99EC80-C26F-43DD-994F-FACB93E3E002 Q34405999-DABDCBA2-9AE5-4A76-9950-5C9E85A6D29B Q35104959-BF0D1167-E7EB-45FF-9869-ADA1B585D143 Q36143785-6162F3B2-D70A-447D-B0A1-9960197AF4ED Q36193915-26729F5C-F089-44DC-A7E4-A6DA7F00BCB3 Q36318598-9461E415-A226-44BD-B6E0-7D2A358485E3 Q36927536-C5E47FCA-287B-41E5-A0C3-A04AE1015018 Q36947501-2E8A3107-4A70-4B50-8A86-6058C874200D Q37211755-E09FE56B-2431-4310-99C1-6AD35FB2A172 Q38223118-BDB436BF-B122-42A7-AFCC-9CDA64330939 Q39160051-0C112F9F-969C-4598-A88F-3BE458B561DE Q41020865-BC1D5AB6-400B-413E-B4D0-48DB9043070A Q41337904-9ED2CCE1-CBA4-4CCF-820C-0908DD91622E Q41518191-2FD5E547-CBE5-440F-8DCF-A1694F29472E Q41789753-0B49C5C0-1177-4881-BF87-4483B42BDC59 Q42473091-1785CCC2-958B-45BA-9348-893FF4B29676 Q42474354-460EB99E-8029-490B-A524-DCF689D514C1 Q43137475-77A0872D-5D98-4C8E-BF7F-4792BB772F89 Q43938517-1FABE21E-5A94-4006-BB37-03DC88339AA4 Q44165271-444B9904-6448-49C4-8460-D68F1D0C3174 Q47837913-E50A745B-7A35-4946-A024-AD2B92DDE66D Q51371295-DAC19DD4-B596-4E17-9FA1-393960535A05 Q54135459-98E95797-B540-4E45-93FB-E3AA5C1DB86F Q57817274-A7998C31-8EB7-415E-A23E-0B2A285FF71B

P2860

Dopaminergic and cholinergic lesions in progressive supranuclear palsy.

http://www.wikidata.org/entity/Q42205368

description

1985 nî lūn-bûn

@nan

1985年の論文

@ja

1985年論文

@yue

1985年論文

@zh-hant

1985年論文

@zh-hk

1985年論文

@zh-mo

1985年論文

@zh-tw

1985年论文

@wuu

1985年论文

@zh

1985年论文

@zh-cn

name

Dopaminergic and cholinergic lesions in progressive supranuclear palsy.

@en

Dopaminergic and cholinergic lesions in progressive supranuclear palsy.

@nl

type

label

Dopaminergic and cholinergic lesions in progressive supranuclear palsy.

@en

Dopaminergic and cholinergic lesions in progressive supranuclear palsy.

@nl

prefLabel

Dopaminergic and cholinergic lesions in progressive supranuclear palsy.

@en

Dopaminergic and cholinergic lesions in progressive supranuclear palsy.

@nl

P1433

Q42205368-054DF23A-A380-42B9-9B67-6A7D5191A6BC

P1476

Q42205368-F46E2B8A-B876-4D97-A8B5-E17D0EB2A67F

P2093

Q42205368-058FAB23-6279-40C0-9AAD-B02EB77B51DE

Q42205368-23CD3E26-367C-4CBF-B429-727EE7E2A412

Q42205368-2AF41854-9147-4F13-8298-1FE2FFC3C959

Q42205368-316E1C23-66F6-4186-B571-B730FD986775

Q42205368-45DF2CD8-C4FC-4350-82E2-42E1344139A8

Q42205368-4C972E09-25C2-4098-A648-5E9B84DC1C9A

Q42205368-5AAC8BCC-B930-46A6-B76A-DC60DC2EBDA9

Q42205368-9812AFCB-DBAD-4A2C-92BC-04D5407ADCC5

Q42205368-B62531B1-1273-49EB-AF82-F7B5E1954019

Q42205368-D6B71FC6-F70C-4C9A-8EF9-95FAD104B064

P2860

Q42205368-289CB0F1-25E2-450C-8560-52699CE0F9B1

Q42205368-2A5B2028-8CF4-4715-B6AA-DF3BC279DD00

P304

Q42205368-52C3F5AF-7275-4F3F-A1E2-E257BDCEBA37

P31

Q42205368-1379CF17-FCDF-4A10-83D5-715F06D00AA4

P356

Q42205368-85C3043F-72A0-4849-ABE9-B2873558D8C4

P433

Q42205368-7E118862-6258-44C9-A8C4-6D90D8CAFFF4

P478

Q42205368-D76B7B97-FE69-4D99-A8FA-6D6489952578

P577

Q42205368-28D25DFF-70BA-4FD5-85D6-955FB763A5DF

P698

Q42205368-3E85B1C9-7B31-4F2F-AC2C-857B24C72B8D

P921

Q42205368-7FBE5C8D-7B8D-49DA-990A-93DC772A7024

P356

P1433

Annals of Neurology

P1476

Dopaminergic and cholinergic lesions in progressive supranuclear palsy.

@en

P2093

Duyckaerts C

http://www.w3.org/2001/XMLSchema#string

Gray F

http://www.w3.org/2001/XMLSchema#string

Hauw JJ

http://www.w3.org/2001/XMLSchema#string

Hirsch E

http://www.w3.org/2001/XMLSchema#string

Javoy-Agid F

http://www.w3.org/2001/XMLSchema#string

LHeureux R

http://www.w3.org/2001/XMLSchema#string

Morel-Maroger A

http://www.w3.org/2001/XMLSchema#string

Rascol A

http://www.w3.org/2001/XMLSchema#string

Ruberg M

http://www.w3.org/2001/XMLSchema#string

Scatton B

http://www.w3.org/2001/XMLSchema#string

P2860

PROGRESSIVE SUPRANUCLEAR PALSY. A HETEROGENEOUS DEGENERATION INVOLVING THE BRAIN STEM, BASAL GANGLIA AND CEREBELLUM WITH VERTICAL GAZE AND PSEUDOBULBAR PALSY, NUCHAL DYSTONIA AND DEMENTIA.

Is the mesocortical dopaminergic system involved in Parkinson disease?

P304

523-529

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ANA.410180503

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P577

1985-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

3000280

http://www.w3.org/2001/XMLSchema#string

P921